{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:37:44Z","timestamp":1793889464312,"version":"4.8.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.amjms.2025.10.011","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:54:32Z","timestamp":1761116072000},"page":"133-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The fungus among us: Emerging and re-emerging fungal infections"],"prefix":"10.1016","volume":"371","author":[{"given":"Jonathan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy S","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.amjms.2025.10.011_bib0001","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.011_bib0002","article-title":"Fungal infections: pathogenesis, antifungals and alternate treatment approaches","volume":"3","author":"Reddy","year":"2022","journal-title":"Curr Res Microb Sci"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.011_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100187","article-title":"What is new in fungal infections?","volume":"36","author":"Parsons","year":"2023","journal-title":"Mod Pathol"},{"issue":"6390","key":"10.1016\/j.amjms.2025.10.011_bib0004","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aap7999","article-title":"Worldwide emergence of resistance to antifungal drugs challenges human health and food security","volume":"360","author":"Fisher","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.011_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.amjms.2025.10.011_bib0006","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1086\/323759","article-title":"Revisiting the source of Candidemia: skin or gut?","volume":"33","author":"Nucci","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.amjms.2025.10.011_bib0007","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.011_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1123200","article-title":"Intestinal colonization with Candida auris and mucosal immune response in mice treated with cefoperazone oral antibiotic","volume":"14","author":"Das","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.011_bib0009","doi-asserted-by":"crossref","first-page":"ofac078","DOI":"10.1093\/ofid\/ofac078","article-title":"Candidemia among coronavirus disease 2019 patients in Turkey admitted to intensive care units: a retrospective multicenter study","volume":"9","author":"Arastehfar","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.011_bib0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/jof8050451","article-title":"Impact of the COVID-19 pandemic on the clinical profile of candidemia and the incidence of fungemia due to fluconazole-resistant Candida parapsilosis","volume":"8","author":"Ramos-Mart\u00ednez","year":"2022","journal-title":"J Fungi"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.011_bib0011","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/antibiotics11060771","article-title":"Epidemiology of Candidemia and fluconazole resistance in an ICU before and during the COVID-19 pandemic era","volume":"11","author":"Routsi","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.011_bib0012","doi-asserted-by":"crossref","first-page":"ofae264","DOI":"10.1093\/ofid\/ofae264","article-title":"Molecular and epidemiological investigation of fluconazole-resistant Candida parapsilosis\u2014Georgia, United States, 2021","volume":"11","author":"Misas","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.011_bib0013","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.diagmicrobio.2011.05.014","article-title":"Microsatellite multilocus genotyping clarifies the relationship of Candida parapsilosis strains involved in a neonatal intensive care unit outbreak","volume":"71","author":"Vaz","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.011_bib0014","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/EC.00181-13","article-title":"Characterization of biofilm formation and the role of BCR1 in clinical isolates of Candida parapsilosis","volume":"13","author":"Pannanusorn","year":"2014","journal-title":"Eukaryotic Cell"},{"issue":"12","key":"10.1016\/j.amjms.2025.10.011_bib0015","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.011_bib0016","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.011_bib0017","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","article-title":"Echinocandin resistance: an emerging clinical problem?","volume":"27","author":"Arendrup","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.011_bib0018","series-title":"Population-Based Active Surveillance For Culture-Confirmed Candidemia \u2014 Four Sites, United States, 2012\u20132016. MMWR Surveill Summ [Internet]","author":"Toda","year":"2019"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.011_bib0019","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital","volume":"53","author":"Satoh","year":"2009","journal-title":"Microbiol. Immunol."},{"issue":"20","key":"10.1016\/j.amjms.2025.10.011_bib0020","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1056\/NEJMra2402635","article-title":"Candida auris Infections","volume":"391","author":"Lionakis","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.011_bib0021","article-title":"Candida auris emergence as a consequence of climate change: impacts on Americas and the need to contain greenhouse gas emissions","volume":"11","author":"Ellwanger","year":"2022","journal-title":"The Lancet Regional Health - Americas [Internet]"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.011_bib0022","doi-asserted-by":"crossref","first-page":"ofaa620","DOI":"10.1093\/ofid\/ofaa620","article-title":"Candida auris colonization after discharge to a community setting: New York City, 2017\u20132019","volume":"8","author":"Bergeron","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.011_bib0023","series-title":"Infection Control Guidance: Candida auris. Candida auris (C. Auris)","year":"2025"},{"issue":"6665","key":"10.1016\/j.amjms.2025.10.011_bib0024","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.adf8972","article-title":"A Candida auris-specific adhesin, SCF1, governs surface association, colonization, and virulence","volume":"381","author":"Santana","year":"2023","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00406-21","article-title":"Candida auris Cell Wall Mannosylation Contributes to Neutrophil Evasion through Pathways Divergent from Candida albicans and Candida glabrata","volume":"6","author":"Horton","year":"2021","journal-title":"mSphere"},{"issue":"11","key":"10.1016\/j.amjms.2025.10.011_bib0026","doi-asserted-by":"crossref","first-page":"e753","DOI":"10.1093\/cid\/ciaa1462","article-title":"Factors associated with Candida auris colonization and transmission in skilled nursing facilities with ventilator units, New York, 2016\u20132018","volume":"72","author":"Rossow","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.011_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00053-22","article-title":"Candida auris pan-drug-resistant to four classes of antifungal agents","volume":"66","author":"Jacobs","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.amjms.2025.10.011_bib0028","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/M22-3469","article-title":"Worsening spread of Candida auris in the United States, 2019 to 2021","volume":"176","author":"Lyman","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjms.2025.10.011_bib0029","doi-asserted-by":"crossref","unstructured":"Wiederhold N.P., Najvar L.K., Olivo M., Morris K.N., Patterson H.P., Catano G., et al. Ibrexafungerp demonstrates in vitro activity against fluconazole-resistant Candida auris and in vivo efficacy with delayed initiation of therapy in an experimental model of invasive Candidiasis. Antimicrob Agents Chemother. 65(6):e02694-20.","DOI":"10.1128\/AAC.02694-20"},{"issue":"15","key":"10.1016\/j.amjms.2025.10.011_bib0030","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.011_bib0031","doi-asserted-by":"crossref","first-page":"e01419","DOI":"10.1128\/aac.01419-22","article-title":"Clinical efficacy and safety of a novel antifungal, fosmanogepix, in patients with Candidemia caused by Candida auris: results from a phase 2 trial","volume":"67","author":"Vazquez","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.amjms.2025.10.011_bib0032","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/pathogens11090957","article-title":"Current topics in dermatophyte classification and clinical diagnosis","volume":"11","author":"Moskaluk","year":"2022","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.011_bib0033","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/jof6040310","article-title":"Epidemiology and diagnostic perspectives of dermatophytoses","volume":"6","author":"Petrucelli","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.011_bib0034","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/myc.13212","article-title":"Invasive dermatophyte infection: a systematic review","volume":"64","author":"Wang","year":"2021","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.011_bib0035","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3109\/13693780903213512","article-title":"Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: case report and review of the literature","volume":"48","author":"Marconi","year":"2010","journal-title":"Med Mycol"},{"issue":"1\u20132","key":"10.1016\/j.amjms.2025.10.011_bib0036","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11046-016-0073-9","article-title":"Toward a novel multilocus phylogenetic taxonomy for the dermatophytes","volume":"182","author":"de Hoog","year":"2017","journal-title":"Mycopathologia"},{"issue":"10","key":"10.1016\/j.amjms.2025.10.011_bib0037","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.eimc.2019.02.010","article-title":"Epidemiology of dermatophytic infections between 2008 and 2017 in Barcelona, Spain","volume":"37","author":"Antuori","year":"2019","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.011_bib0038","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12281-015-0231-4","article-title":"Trends in epidemiology and diagnostic approach","volume":"9","author":"Hayette","year":"2015","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.amjms.2025.10.011_bib0039","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2023-5-1","article-title":"Tinea pedis: an updated review","volume":"12","author":"Leung","year":"2023","journal-title":"Drugs Context"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.011_bib0040","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0190-9622(03)02117-0","article-title":"Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002","volume":"50","author":"Foster","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.011_bib0041","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/0019-5154.82476","article-title":"Pathogenesis of dermatophytoses","volume":"56","author":"Tainwala","year":"2011","journal-title":"Indian J Dermatol"},{"issue":"8","key":"10.1016\/j.amjms.2025.10.011_bib0042","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/jof7080629","article-title":"State-of-the-Art dermatophyte infections: epidemiology aspects, pathophysiology, and resistance mechanisms","volume":"7","author":"Martinez-Rossi","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.011_bib0043","first-page":"101","article-title":"Dermatophyte infections","volume":"67","author":"Hainer","year":"2003","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.011_bib0044","first-page":"1","article-title":"Dermatophyte infections worldwide: increase in incidence and associated antifungal resistance","volume":"14","author":"Kruithoff","year":"2023","journal-title":"Life (Basel)"},{"issue":"10","key":"10.1016\/j.amjms.2025.10.011_bib0045","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s00105-021-04879-1","article-title":"Terbinafine-resistant dermatophytoses and onychomycosis due to Trichophyton rubrum]","volume":"72","author":"Appelt","year":"2021","journal-title":"Hautarzt"},{"issue":"10","key":"10.1016\/j.amjms.2025.10.011_bib0046","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01126-19","article-title":"Emerging terbinafine resistance in trichophyton: clinical characteristics, squalene epoxidase gene mutations, and a reliable EUCAST method for detection","volume":"63","author":"Saunte","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.011_bib0047","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02522-17","article-title":"Mutation in the squalene epoxidase gene of trichophyton interdigitale and trichophyton rubrum associated with allylamine resistance","volume":"62","author":"Rudramurthy","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.011_bib0048","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/bjd.19420","article-title":"Treatment-resistant tinea corporis, a potential public health issue","volume":"184","author":"Chen","year":"2021","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.011_bib0049","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/myc.12772","article-title":"High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene","volume":"61","author":"Singh","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.amjms.2025.10.011_bib0050","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7219a4","article-title":"Notes from the field: first reported U.S. cases of tinea caused by trichophyton indotineae \u2014 New York City, December 2021\u2013March 2023","volume":"72","author":"Caplan","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.amjms.2025.10.011_bib0051","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41579-023-00960-9","article-title":"The rapid emergence of antifungal-resistant human-pathogenic fungi","volume":"21","author":"Lockhart","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"10.1016\/j.amjms.2025.10.011_bib0052","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.3390\/jcm13123558","article-title":"Trichophyton indotineae, an emerging drug-resistant dermatophyte: a review of the treatment options","volume":"13","author":"Sonego","year":"2024","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.011_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2022.101306","article-title":"Multidrug resistant tinea corporis\/cruris: response to voriconazole","volume":"32","author":"Khurana","year":"2022","journal-title":"J Mycol Med"},{"issue":"12","key":"10.1016\/j.amjms.2025.10.011_bib0054","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S1473-3099(21)00191-2","article-title":"Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology","volume":"21","author":"Thompson","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.011_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8491383","article-title":"Fungal dimorphism and virulence: molecular mechanisms for temperature adaptation, immune evasion, and in vivo survival","volume":"2017","author":"Gauthier","year":"2017","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.011_bib0056","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/jof7020151","article-title":"Endemic and other dimorphic mycoses in The Americas","volume":"7","author":"Lockhart","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"11","key":"10.1016\/j.amjms.2025.10.011_bib0057","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S1473-3099(17)30306-7","article-title":"Neglected endemic mycoses","volume":"17","author":"Queiroz-Telles","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.011_bib0058","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s11046-020-00431-2","article-title":"Re-drawing the maps for endemic mycoses","volume":"185","author":"Ashraf","year":"2020","journal-title":"Mycopathologia"},{"issue":"9","key":"10.1016\/j.amjms.2025.10.011_bib0059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007977","article-title":"Emergomyces: the global rise of new dimorphic fungal pathogens","volume":"15","author":"Schwartz","year":"2019","journal-title":"PLoS Pathog."},{"issue":"15","key":"10.1016\/j.amjms.2025.10.011_bib0060","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1215460","article-title":"A dimorphic fungus causing disseminated infection in South Africa","volume":"369","author":"Kenyon","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.amjms.2025.10.011_bib0061","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/1346-8138.12975","article-title":"Disseminated infection caused by Emmonsia pasteuriana in a renal transplant recipient","volume":"42","author":"Feng","year":"2015","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.011_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2022.101313","article-title":"Review: emergomycosis","volume":"33","author":"Reddy","year":"2023","journal-title":"J Mycol Med"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.011_bib0063","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/civ439","article-title":"Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series","volume":"61","author":"Schwartz","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.011_bib0064","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1128\/JCM.02524-16","article-title":"In vitro antifungal susceptibility of yeast and mold phases of isolates of dimorphic fungal pathogen emergomyces africanus (Formerly Emmonsia sp.) from HIV-infected South African patients","volume":"55","author":"Maphanga","year":"2017","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.amjms.2025.10.011_bib0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3201\/eid2403.171258","article-title":"Multistate epidemiology of histoplasmosis, United States, 2011-2014","volume":"24","author":"Armstrong","year":"2018","journal-title":"Emerg Infect Dis."},{"issue":"10","key":"10.1016\/j.amjms.2025.10.011_bib0066","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3201\/eid2410.180032","article-title":"Mapping Histoplasma capsulatum Exposure, United States","volume":"24","author":"Maiga","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.011_bib0067","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/CMR.00056-09","article-title":"Clinical and laboratory update on blastomycosis","volume":"23","author":"Saccente","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.011_bib0068","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cid\/ciae513","article-title":"Epidemiological and clinical features of a large blastomycosis outbreak at a paper mill in Michigan","volume":"80","author":"Hennessee","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.011_bib0069","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/cid\/ciy483","article-title":"Blastomyces helicus, a new dimorphic fungus causing fatal pulmonary and systemic disease in humans and animals in Western Canada and the United States","volume":"68","author":"Schwartz","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.amjms.2025.10.011_bib0070","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1029\/2019GH000209","article-title":"Expansion of coccidioidomycosis endemic regions in the United States in response to climate change","volume":"3","author":"Gorris","year":"2019","journal-title":"GeoHealth"},{"key":"10.1016\/j.amjms.2025.10.011_bib0071","series-title":"Reported Cases of Valley Fever","year":"2024"},{"key":"10.1016\/j.amjms.2025.10.011_bib0072","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2334-13-29","article-title":"Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes","volume":"13","author":"Baddley","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.011_bib0073","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.10.011_bib0074","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"179","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.amjms.2025.10.011_bib0075","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jama.2023.28019","article-title":"Prevalence of Immunosuppression among US adults","volume":"331","author":"Martinson","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.011_bib0076","doi-asserted-by":"crossref","first-page":"ofw268","DOI":"10.1093\/ofid\/ofw268","article-title":"Trends in hospitlizations related to invasive aspergillosis and mucormycosis in the United States, 2000-2013","volume":"4","author":"Vallabhaneni","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"supp 1","key":"10.1016\/j.amjms.2025.10.011_bib0077","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dkx028","article-title":"Changes in the epidemiological landscape of invasive mould infections and disease","volume":"72","author":"Lass-Florl","year":"2017","journal-title":"J Antimicrob Therapy"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.011_bib0078","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","article-title":"Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany","volume":"70","author":"Steinmann","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.011_bib0079","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus Fumigatus: can we retain the Clinical use of mold-active antifungal azoles?","volume":"61","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"30","key":"10.1016\/j.amjms.2025.10.011_bib0080","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjms.2025.10.011_bib0081","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on infections in leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.amjms.2025.10.011_bib0082","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13525","article-title":"Emerging fungal infections in solid organ transplant recipients: guidelines of the American society of transplantation infectious diseases community of practice","volume":"33","author":"Shoham","year":"2019","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.011_bib0083","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00053-22","article-title":"Candida auris pan-drug-resistant to four classes of antifungal agents","volume":"66","author":"Jacobs","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.011_bib0084","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cid\/ciae203","article-title":"Breakthrough invasive fungal infections in patients with high-risk hematological disorders receiving voriconazole and posaconazole prophylaxis: a systematic review","volume":"79","author":"Boutin","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.011_bib0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jinf.2023.05.005","article-title":"Breakthrough invasive fungal infection among patients with haematologic malignancies: a national prospective, and multicentre study","volume":"87","author":"Puerta-Alcade","year":"2023","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.011_bib0086","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12908","article-title":"Lomentospora prolificans fungemia in hematopoietic stem cell transplant patients: first report in South America and literature review","volume":"20","author":"Penteado","year":"2018","journal-title":"Transplant Infectious Disease"},{"key":"10.1016\/j.amjms.2025.10.011_bib0087","series-title":"WHO Fungal Priority Pathogens to Guide research, development, and Public Health action. WHO","year":"2022"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.011_bib0088","doi-asserted-by":"crossref","first-page":"ofad093","DOI":"10.1093\/ofid\/ofad093","article-title":"Invasive mold infections following Hurricane Harvey\u2014Houston, Texas","volume":"10","author":"Toda","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.011_bib0089","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1056\/NEJMoa1204781","article-title":"Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011","volume":"367","author":"Neblett-Fanfair","year":"2012","journal-title":"N Eng J Med"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.011_bib0090","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02854-22","article-title":"Postinfluenza environment reduces A. fumigatis conidium clearance and facilitates invasive aspergillosis in vivo","volume":"13","author":"Liu","year":"2022","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.011_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2023.105264","article-title":"The influenza A virus promotes fungal growth of A. fumigatis via direct interaction in vitro","volume":"26","author":"Konig","year":"2024","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.011_bib0092","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41479-024-00129-9","article-title":"Invasive pulmonary aspergillosis among patients with severe community-acquired pneumonia and influenza in ICUs: a retrospective cohort study","volume":"16","author":"Lee","year":"2024","journal-title":"Pneumonia"},{"key":"10.1016\/j.amjms.2025.10.011_bib0093","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intens Care Med"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.011_bib0094","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jmii.2022.12.004","article-title":"COVID-19 associated mold infections: review of COVID-19 associated pulmonary aspergillosis and mucormycosis","volume":"56","author":"Huang","year":"2023","journal-title":"J Micro, Immun, and Infect"},{"key":"10.1016\/j.amjms.2025.10.011_bib0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47231-4","article-title":"Absence of COVID-19 associated mucormycosis in a tertiary intensive care unit in the Netherlands","volume":"13","author":"Schippers","year":"2023","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.011_bib0096","first-page":"1433","article-title":"Increased hospitalizations involving fungal infections during COVID-19 pandemic, United States, January 2020-December 2021","volume":"29","author":"Gold","year":"2023","journal-title":"EID"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.011_bib0097","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1002\/hsr2.789","article-title":"Comparative risk assessment of COVID-19 associated mucormycosis and aspergillosis: a systematic review","volume":"18","author":"Baral","year":"2022","journal-title":"Health Sci Rep"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.011_bib0098","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of Mucormycosis in India","volume":"9","author":"Prakash","year":"2021","journal-title":"Microorganisms"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:54:49Z","timestamp":1769090089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925012479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0002962925012479"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.10.011","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The fungus among us: Emerging and re-emerging fungal infections","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}